EDGAR Filing Documents for 0001144204-18-011793

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001144204-18-011793

Filing Date

2018-02-28

Accepted

2018-02-28 16:32:02

Documents

101

Period of Report

2017-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	v485049_10k.htm	10-K	2173032
2	EXHIBIT 10.2.1	tv485049_ex10x2x1.htm	EX-10.2.1	50503
3	EXHIBIT 10.8	tv485049_ex10-8.htm	EX-10.8	82798
4	EXHIBIT 10.21	tv485049_ex10-21.htm	EX-10.21	28222
5	EXHIBIT 12.1	v485049_exhx12x1.htm	EX-12.1	10771
6	EXHIBIT 21.1	v485049_exhx21x1.htm	EX-21.1	7476
7	EXHIBIT 23.1	v485049_exhx23x1.htm	EX-23.1	4134
8	EXHIBIT 31.1	v485049_exhx31x1.htm	EX-31.1	15395
9	EXHIBIT 31.2	v485049_exhx31x2.htm	EX-31.2	15384
10	EXHIBIT 32	v485049_exhx32.htm	EX-32	5659
17	GRAPHIC	line.gif	GRAPHIC	43
18	GRAPHIC	spacer.gif	GRAPHIC	43
19	GRAPHIC	v485049_chrt-pipeline.jpg	GRAPHIC	79829
20	GRAPHIC	v485049_chrt-bar1.jpg	GRAPHIC	137768
21	GRAPHIC	v485049_chrt-bar2.jpg	GRAPHIC	218135
22	GRAPHIC	v485049_chrt-line.jpg	GRAPHIC	221236
	Complete submission text file	0001144204-18-011793.txt		10563759

Data Files

Seq	Description	Document	Type	Size
11	XBRL INSTANCE FILE	icpt-20171231.xml	EX-101.INS	2484778
12	XBRL SCHEMA FILE	icpt-20171231.xsd	EX-101.SCH	52605
13	XBRL CALCULATION FILE	icpt-20171231_cal.xml	EX-101.CAL	73905
14	XBRL DEFINITION FILE	icpt-20171231_def.xml	EX-101.DEF	154901
15	XBRL LABEL FILE	icpt-20171231_lab.xml	EX-101.LAB	426164
16	XBRL PRESENTATION FILE	icpt-20171231_pre.xml	EX-101.PRE	383000

Mailing Address 450 W. 15TH STREET SUITE 505 New York NY 10011

Business Address 450 W. 15TH STREET SUITE 505 NEW YORK NY 10011 646-747-1000

INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)